Buzzing Politics
  • News
  • Privacy Policy
  • Terms of Use
  • Disclaimer
Select Page

SanDisk Stock Drops Friday Afternoon: What’s Driving the Action?

by Henry Khederian | Sep 11, 2026 | General

Shares of SanDisk Corp. (NASDAQ:SNDK) are trading lower Friday afternoon as sector-wide software efficiency concerns weigh on storage and memory equities. SanDisk stock is among today’s weakest performers. Why are SNDK shares down? DeepSeek V4.1 Flash Architecture...

Oracle’s AI Cloud Boom Puts These ETFs in Focus as Cloud Infrastructure Growth Hits 121%

by Chandrima Sanyal | Sep 11, 2026 | General

Oracle Corp‘s (NYSE:ORCL) accelerating AI cloud business is giving investors another way to play the artificial intelligence boom beyond Nvidia and other chipmakers, putting AI-focused ETFs with exposure to the software giant in focus. Oracle reported first-quarter...

Bitcoin Has Bottomed, Analyst Says: ‘We’re Not Going Back to Those Lows’

by Parshwa Turakhiya | Sep 11, 2026 | General

Macro investor Dan Tapiero told The Wolf of All Streets podcast on Friday that Bitcoin (CRYPTO: BTC) has already bottomed and the low will not be revisited. What Tapiero Said About the Bottom Tapiero said the real catalyst behind Bitcoin’s bottom was not the...

Bitcoin, Ethereum, XRP, Dogecoin Whipsaw, Brace for ‘Classic Weekend Sweep’

by Khyathi Dalal | Sep 11, 2026 | General

Bitcoin briefly topped $79,000 before pulling back markets await next week’s interest rate decision and the CLARITY Act vote.CryptocurrencyTickerPriceBitcoin(CRYPTO: BTC)$77,492.87Ethereum(CRYPTO: ETH)$2,565.59Solana(CRYPTO: SOL)$101.82XRP(CRYPTO:...

Why Is American Airlines Stock Surging on Friday?

by Kaustubh Bagalkote | Sep 11, 2026 | General

American Airlines Group Inc. (NYSE:AAL) stock traded higher on Friday, alongside a broader market rally. The upward movement followed a relief pullback in crude oil prices, which fell below $100 a barrel. The Nasdaq is up 1.15% while the S&P 500 has gained 1.08%....

Exelixis Stock Slips as FDA Delays Cancer Drug Review, Analyst Weighs In

by Vandana Singh | Sep 11, 2026 | General

On Friday, the U.S. Food and Drug Administration (FDA) extended the review period for Exelixis Inc.‘s (NASDAQ:EXEL) new drug application (NDA) for zanzalintinib, in combination with atezolizumab, for metastatic colorectal cancer by three months. • Exelixis stock is...
« Older Entries
Next Entries »

Recent Posts

  • Consumer Tech (Sep 7-11): Apple Launches First Foldable iPhone, XPeng Commissioned IRON Humanoid Robot Production & More
  • Peter Schiff Tells People This Is What They Need to Do if They Want to Succeed: ‘You’re Not Going to Make a Lot of Money as an Employee’
  • Middle East Fighting Spreads, Lifting Rate Hike Risks and Pushing Oil Higher As Saudi Pipeline Shutdown Deepens Crisis
  • Bitcoin’s iPhone Ratio Crashed 99.99% Since 2011: Here’s How Much 1 iPhone Cost Back Then
  • A Dating App Is Outperforming Apple, Meta and Microsoft on This Metric— Only Nvidia Can Claim a Higher Number

Recent Comments

    Archives

    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • June 2019

    Categories

    • Breaking
    • Business
    • Daily
    • General
    • Markets
    • News
    • Reports
    • Technology

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • News
    • Privacy Policy
    • Terms of Use
    • Disclaimer
    Copyright 2019 Karmaholic Media LLC. All Rights Reserved.